Puneeth Iyengar on the Benefits of Hypofractionated Radiation Therapy in Lung Cancer

Throughout April, the FDA approved drugs for the treatment of diseases including solid tumors, lung cancer, multiple myeloma, bladder cancer, and low-grade glioma.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

A pilot study proved that a nurse-coordinated approach shows promise in treating more than just 1 symptom among patients with cancer.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Fast track designation has been granted by the FDA to PT217 for extensive stage small cell lung cancer with disease progression.

Alectinib was approved for the treatment of patients with ALK-positive non-small cell lung cancer after surgical resection.